INOMAX

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Dec 23, 1999

   26 yr 11 mo ago

2. Today

3. Patent 11931377 expires

   Listed drug substance patent expiration.

   Jun 30, 2029

   in 3 yr 1 mo

4. Patent 8282966 expires

   Listed method-of-use patent (U-1286) expiration.

   Jun 30, 2029

   in 3 yr 1 mo

5. Patent 8293284 expires

   Listed method-of-use patent (U-1286) expiration.

   Jun 30, 2029

   in 3 yr 1 mo

6. Patent 8431163 expires

   Listed method-of-use patent (U-1286) expiration.

   Jun 30, 2029

   in 3 yr 1 mo

7. Patent 8795741 expires

   Listed method-of-use patent (U-1286) expiration.

   Jun 30, 2029

   in 3 yr 1 mo

8. Patent 8846112 expires

   Listed method-of-use patent (U-1286) expiration.

   Jun 30, 2029

   in 3 yr 1 mo

9. Patent 11931377*PED expires

   Listed listed patent expiration.

   Dec 30, 2029

   in 3 yr 7 mo

10. Patent 8282966*PED expires

    Listed listed patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

11. Patent 8293284*PED expires

    Listed listed patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

12. Patent 8431163*PED expires

    Listed listed patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

13. Patent 8795741*PED expires

    Listed listed patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

14. Patent 8846112*PED expires

    Listed listed patent expiration.

    Dec 30, 2029

    in 3 yr 7 mo

15. Patent 8291904 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

16. Patent 8573209 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

17. Patent 8573210 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

18. Patent 8776794 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

19. Patent 8776795 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

20. Patent 9265911 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

21. Patent 9295802 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

22. Patent 9408993 expires

    Listed drug product patent expiration.

    Jan 06, 2031

    in 4 yr 7 mo

23. Patent 8291904*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

24. Patent 8573209*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

25. Patent 8573210*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

26. Patent 8776794*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

27. Patent 8776795*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

28. Patent 9265911*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

29. Patent 9295802*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

30. Patent 9408993*PED expires

    Listed listed patent expiration.

    Jul 06, 2031

    in 5 yr 1 mo

31. Patent 9279794 expires

    Listed drug product patent expiration.

    Feb 19, 2035

    in 8 yr 10 mo

32. Patent 9279794*PED expires

    Listed listed patent expiration.

    Aug 19, 2035

    in 9 yr 4 mo

33. Patent 9770570 expires

    Listed method-of-use patent (U-2148) expiration.

    May 03, 2036

    in 10 yr

34. Patent 9770570*PED expires

    Listed listed patent expiration.

    Nov 03, 2036

    in 10 yr 6 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• GENOSYLBrand (NDA)

  NDA 202860 · VERO BIOTECH INC

  2019
• ULSPIRAGeneric (ANDA)

  ANDA 203144 · AIRGAS THERAP

  2023
• NOXIVENTGeneric (ANDA)

  ANDA 207141 · VERO BIOTECH INC

  2018

Listed patents (32)